TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury
Acta Neuropathologica · 2024
DOI: 10.1007/s00401-024-02840-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Beate Hartmannsberger und 17 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Interdisciplinary Pain Medicine, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg,…. Hauptthemen laut MEDLINE: Neuralgia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Universitätsklinikum Würzburg.
Abstract (Originalsprache)
Nerve injury causes neuropathic pain and multilevel nerve barrier disruption. Nerve barriers consist of perineurial, endothelial and myelin barriers. So far, it is unclear whether resealing nerve barriers fosters pain resolution and recovery. To this end, we analysed the nerve barrier property portfolio, pain behaviour battery and lipidomics for precursors of specialized pro-resolving meditators (SPMs) and their receptors in chronic constriction injury of the rat sciatic nerve to identify targets for pain resolution by resealing the selected nerve barriers. Of the three nerve barriers—perineurium, capillaries and myelin—only capillary tightness specifically against larger molecules, such as fibrinogen, recuperated with pain resolution. Fibrinogen immunoreactivity was elevated in rats not only at the time of neuropathic pain but also in nerve biopsies from patients with (but not without) painful polyneuropathy, indicating that sealing of the vascular barrier might be a novel approach in pain treatment. Hydroxyeicosatetraenoic acid (15R-HETE), a precursor of aspirin-triggered lipoxin A4, was specifically upregulated at the beginning of pain resolution. Repeated local application of resolvin D1-laden nanoparticles or Fpr2 agonists sex-independently resulted in accelerated pain resolution and fibrinogen removal. Clearing macrophages ( Cd206) were boosted and fibrinolytic pathways ( Plat) were induced, while inflammation ( Tnfα) and inflammasomes ( Nlrp3) were unaffected by this treatment. Blocking TAM receptors (Tyro3, Axl and Mer) and tyrosine kinase receptors linking haemostasis and inflammation completely inhibited all the effects. In summary, nanoparticles can be used as transporters for fleeting lipids, such as SPMs, and therefore expand the array of possible therapeutic agents. Thus, the Fpr2–Cd206–TAM receptor axis may be a suitable target for strengthening the capillary barrier, removing endoneurial fibrinogen and boosting pain resolution in patients with chronic neuropathic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Interdisciplinary Pain Medicine, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, Würzburg, Germany.
- Helmholtz Institute for Metabolic, Obesity and Vascular Research, Diet-Induced Metabolic Alterations Group, Leipzig, Germany.
- Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
- Goethe University, Frankfurt, Faculty of Medicine, Institute of Clinical Pharmacology, Frankfurt Am Main, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, and Fraunhofer Cluster of Excellence of Immune Mediate Diseases CIMD, Frankfurt Am Main, Germany.
- George W. Woodruff School of Mechanical Engineering, Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, USA.
Förderung
- Deutsche Forschungsgemeinschaft
- Universitätsklinikum Würzburg
Zitieren
APA
Hartmannsberger, B., Ben-Kraiem, A., Kramer, S., Guidolin, C., Kazerani, I., Doppler, K., Thomas, D., Gurke, R., Sisignano, M., Kalelkar, P. P., García, A. J., Monje, P. V., Sammeth, M., Nusrat, A., Brack, A., Krug, S. M., Sommer, C., & Rittner, H. L. (2024). TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02840-9
Vancouver
Hartmannsberger B, Ben-Kraiem A, Kramer S, Guidolin C, Kazerani I, Doppler K, et al. TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02840-9
BibTeX
@article{Hartmannsberger2024,
author = {Hartmannsberger, Beate and Ben-Kraiem, Adel and Kramer, Sofia and Guidolin, Carolina and Kazerani, Ida and Doppler, Kathrin and Thomas, Dominique and Gurke, Robert and Sisignano, Marco and Kalelkar, Pranav P and García, Andrés J and Monje, Paula V and Sammeth, Michael and Nusrat, Asma and Brack, Alexander and Krug, Susanne M and Sommer, Claudia and Rittner, Heike L},
title = {TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury},
journal = {Acta Neuropathologica},
year = {2024},
doi = {10.1007/s00401-024-02840-9}
}
EUVIMED